PU¶PubMed·Journal article·Research (general)·9d agoK V 3.1 channel modulation: a systematic review of pharmacological intervention strategiesKV3.1 channel modulation represents a promising but early-stage pharmacological pathway that could eventually yield novel treatments for auditory processing deficits linked to fast-spiking interneuron dysfunction.
PU✚PubMed·Clinical trial·Vestibular·3w agoPragmatic open-label clinical trial investigating the treatment effects of Ginkgo biloba extract EGb 761 on patients with vertigo and dizziness of various aetiologiesfrom a single open-label (no blinding, no placebo control) pragmatic trial are insufficient to change prescribing or recommendation practice for EGb 761 in vertigo/dizziness management; await higher-quality controlled evidence before adopting.＋Save
PU¶PubMed·Journal article·Research (general)·4w agoCase report: Vogt-Koyanagi-Harada-like uveitis induced by anti-PD-1 therapy (Sintilimab) in a gastric cancer patient: a case studyThis case has no relevance to the audiology field.＋Save
PU¶PubMed·Journal article·Pediatric·2mo agoMechanisms, prevention, and management of aminoglycoside-induced hearing loss in neonates and children: a translational reviewClinicians treating neonates and children with aminoglycosides should be aware of evidence-based monitoring and prevention strategies outlined in this review, but specific protocol changes should be evaluated against local guidelines.＋Save
PU¶PubMed·Journal article·Vestibular·2mo agoBetahistine for residual dizziness after canalith repositioning in benign paroxysmal positional vertigo: a systematic review of randomized controlled trialsAudiologists and vestibular specialists managing post-CRM residual dizziness in BPPV patients should review this systematic review's pooled findings; if betahistine shows significant benefit, it may warrant a protocol update in collaboration with referring physicians.＋Save
PU¶PubMed·Journal article·Tinnitus·3mo agoCorrection: The effect of MemoVigor 2 on recent-onset idiopathic tinnitus: a randomized double-blind placebo-controlled clinical trialThis is a correction notice, not new data — no actionable change; readers should consult the updated version of the original RCT for accurate figures before drawing clinical conclusions about MemoVigor 2 for tinnitus.＋Save
